Zobrazeno 1 - 10
of 1 601
pro vyhledávání: '"Jochemsen A"'
Publikováno v:
In Energy Research & Social Science November 2024 117
Publikováno v:
In Chemometrics and Intelligent Laboratory Systems 15 September 2024 252
Autor:
van der Burg Marja JM, Wiercinska Eliza, Verlaan-de Vries Matty, Lodder Kirsten, Teunisse Amina FAS, de Lange Job, Lenos Kristiaan, Szuhai Karoly, Jochemsen Aart G
Publikováno v:
Molecular Cancer, Vol 10, Iss 1, p 111 (2011)
Abstract Background In around 50% of all human cancers the tumor suppressor p53 is mutated. It is generally assumed that in the remaining tumors the wild-type p53 protein is functionally impaired. The two main inhibitors of p53, hMDM2 (MDM2) and hMDM
Externí odkaz:
https://doaj.org/article/980bf98ae4b540b38d9c868bb3e4e699
Autor:
Arwin Groenewoud, Jie Yin, Maria Chiara Gelmi, Samar Alsafadi, Fariba Nemati, Didier Decaudin, Sergio Roman-Roman, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, Martine J. Jager, Felix B. Engel, B. E. Snaar-Jagalska
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-11 (2023)
Abstract Uveal melanoma (UM) has a high risk to progress to metastatic disease with a median survival of 3.9 months after metastases detection, as metastatic UM responds poorly to conventional and targeted chemotherapy and is largely refractory to im
Externí odkaz:
https://doaj.org/article/35f875d9b6ee4910a5099e5b1b9ef6e8
Publikováno v:
In International Biodeterioration & Biodegradation October 2022 174
Autor:
Barquet, Karina, Morsut, Claudia, Rhinard, Mark, Englund, Mathilda, Mees, Heleen, Engen, Ole Andreas Hegland, Neby, Simon, Jochemsen, Nenya, Angell, Elisabeth
Publikováno v:
Risk, Hazards & Crisis in Public Policy; Dec2024, Vol. 15 Issue 4, p491-517, 27p
Autor:
Jochemsen, Nenya, Mees, Heleen
Publikováno v:
Risk, Hazards & Crisis in Public Policy; Dec2024, Vol. 15 Issue 4, p419-440, 22p
Autor:
Chloé Prunier, Ania Alay, Michiel van Dijk, Kelly L. Ammerlaan, Sharon van Gelderen, Dieuwke L. Marvin, Amina Teunisse, Roderick C. Slieker, Karoly Szuhai, A. G. Jochemsen, Xavier Solé, Peter ten Dijke, Laila Ritsma
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-12 (2021)
Abstract Reactivation of dormant cancer cells can lead to cancer relapse, metastasis, and patient death. Dormancy is a nonproliferative state and is linked to late relapse and death. No targeted therapy is currently available to eliminate dormant cel
Externí odkaz:
https://doaj.org/article/1a7695e25ac44d42a318fcdc5ab8c2ee
Autor:
Jie Yin, Gangyin Zhao, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, Gabriel Forn-Cuní, Annemijn P. A. Wierenga, Martine J. Jager, B. Ewa Snaar-Jagalska, Arwin Groenewoud
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 598 (2023)
Uveal melanoma (UM) is a rare malignant cancer of the eye, with up to 50% of patients dying from metastasis, for which no effective treatment is available. Due to the rarity of the disease, there is a great need to harness the limited material availa
Externí odkaz:
https://doaj.org/article/926cbf25627a4e6385fb3c70e89d75a4
Autor:
Decaudin, Didier, Frisch Dit Leitz, Estelle, Nemati, Fariba, Tarin, Malcy, Naguez, Adnan, Zerara, Mohamed, Marande, Benjamin, Vivet-Noguer, Raquel, Halilovic, Ensar, Fabre, Claire, Jochemsen, Aart, Roman-Roman, Sergio, Alsafadi, Samar
Publikováno v:
In European Journal of Cancer February 2020 126:93-103